| View |
2022-02-03-0026
|
DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
INFANRIX HEXA
|
BR-508
|
A21CE029
|
Packaging Lot (Box): A21CE029A; (PFS): A21LE029A; (Vial): A21FE029A; (Needle 25G x 1): 2102043
|
31 March 2024
|
7 February 2022
|
| View |
2022-04-18-0092
|
DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS, INACTIVATED POLIOMYELITIS AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, ADSORBED
|
INFANRIX-IPV+HIB
|
BR-659
|
A20CB609
|
Packaging Lot (Box): A20CB609A; (Vial): A20FB609A; (Pre-filled Syringe): A20LB609A; (Needles 25G x 1"): 2104028
|
31 March 2024
|
20 April 2022
|
| View |
2022-05-24-0124
|
HUMAN RABIES IMMUNOGLOBULIN
|
BERIRAB P
|
BR-869
|
P100331950
|
Packaging Lot (Pre-filled Syringe): P100397864; (Needle 21G 1 1/2"): 0052487
|
31 March 2024
|
27 May 2022
|
| View |
2022-05-24-0127
|
HUMAN RABIES IMMUNOGLOBULIN
|
BERIRAB P
|
BR-869
|
P100336110
|
Packaging Lot (Pre-filled Syringe): P100411617; (Needle 21G 1 1/2"): 0052487
|
31 March 2024
|
27 May 2022
|
| View |
2022-07-01-0163
|
MEASLES, MUMPS, RUBELLA (MMR) VACCINE (LIVE, ATTENUATED)
|
PRIORIX
|
BR-415
|
A69CF450A
|
Packaging Lot (Box): A69CF450A; (Vial): A69FF450A; (Pre-filled Syringe): A69DF450A; (Needle 25G x 5/8"): 2201042
|
31 March 2024
|
6 July 2022
|
| View |
2022-07-04-0165
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822009
|
Packaging Lot (Box & Vial): A06822009
|
31 March 2024
|
6 July 2022
|
| View |
2022-07-04-0166
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822010
|
Packaging Lot (Box & Vial): A06822010
|
31 March 2024
|
6 July 2022
|
| View |
2022-07-04-0167
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822011
|
Packaging Lot (Box & Vial): A06822011
|
31 March 2024
|
6 July 2022
|
| View |
2022-07-04-0168
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822012
|
Packaging Lot (Box & Vial): A06822012
|
31 March 2024
|
6 July 2022
|
| View |
2022-07-07-0177
|
BCG VACCINE
|
-
|
BR-572
|
0371G102
|
Packaging Lot (Box & Vial): 0371G102; (Ampoule [diluent]): 0701S4005
|
31 March 2024
|
12 July 2022
|
| View |
2022-07-07-0180
|
BCG VACCINE
|
-
|
BR-572
|
0371G101
|
Packaging Lot (Box & Vial): 0371G101; (Diluent): 0640S4037
|
31 March 2024
|
12 July 2022
|
| View |
2022-07-29-0210
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822013
|
Packaging Lot (Box & Vial): A06822013
|
31 March 2024
|
2 August 2022
|
| View |
2022-10-27-0322
|
ROTAVIRUS VACCINE, LIVE
|
ROTATEQ
|
BR-615
|
1482055
|
Packaging Lot (Box & Tube): W025538
|
31 March 2024
|
3 November 2022
|
| View |
2022-05-26-0129
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
|
SYNFLORIX
|
BR-685
|
ASPNB339B
|
Packaging Lot (Box & Vial): ASPNB339BV
|
31 March 2025
|
31 May 2022
|
| View |
2022-08-30-0235
|
HEPATITIS B VACCINE (rDNA)
|
-
|
BR-589
|
0332L003
|
Packaging Lot (Box & Vial): 0332L003
|
31 March 2025
|
1 September 2022
|
| View |
2018-09-18-0205
|
Hepatitis B Vaccine (rDNA)
|
Hepliv
|
BR-501
|
51B18005A
|
Packaging Lot: Box & Vial - 51B18005A
|
31 May 2021
|
20 September 2018
|
| View |
2018-10-09-0225
|
Hepatitis B Vaccine (Recombinant DNA)
|
None
|
BR-589
|
0338L003B
|
Packaging Lot: Box & vial - 0338L003B
|
31 May 2021
|
11 October 2018
|
| View |
2018-10-22-0241
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
280718
|
Packaging Lot: 0280718
|
31 May 2021
|
24 October 2018
|
| View |
2018-11-21-0258
|
Tetanus Toxoid Adsorbed
|
None
|
BR-1025
|
A1700318
|
Packaging Lot: Box & ampoule: A1700318
|
31 May 2021
|
26 November 2018
|
| View |
2019-02-08-0031
|
PNEUMOCOCCAL CONJUGATE VACCINE, 13-VALENT (ADSORBED)
|
Prevenar 13
|
BR-1133
|
X04896
|
Packaging Lot: AL2569, Needle: 1809022, ED: 2023-08-31
|
31 May 2021
|
12 February 2019
|